Atrial Fibrillation Devices Market Report 2026

Atrial Fibrillation Devices Market Overview

• Atrial Fibrillation Devices market size has reached to $8.6 billion in 2025 • Expected to grow to $14.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Growing Prevalence Of Cardiovascular Diseases Fuelling The Growth Of The Atrial Fibrillation Devices Market Due To Unhealthy Lifestyle Habits • Market Trend: Enhancing Diagnostic Accuracy Through Patient-Centric Tools • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Atrial Fibrillation Devices Market?

Atrial fibrillation (AFib) devices are medical technologies designed to detect, monitor, or treat atrial fibrillation, a common heart rhythm disorder where the upper chambers of the heart beat irregularly. These devices include implantable cardiac monitors, pacemakers, defibrillators, catheter ablation systems, and wearable electrocardiogram (ECG) monitors. The primary purpose of atrial fibrillation devices is to restore normal heart rhythm, reduce the risk of stroke, and improve quality of life. The main device type of the atrial fibrillation devices includes implantable devices, external devices, and catheter-based devices. Implantable devices refer to medical devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and implantable loop recorders that are surgically placed inside the body to monitor, regulate, or restore normal heart rhythm by delivering electrical impulses or recording cardiac activity over extended periods. These are used for various applications which include electrophysiology ablation catheters, cardiac monitors or implantable loop recorders, electrophysiology diagnostic catheters, mapping and recording systems, access devices, intracardiac echocardiography, left atrial appendage closure devices, and other related products, enabled by technologies such as radiofrequency, cryotherapy, ultrasound, and other advanced techniques. These are distributed through channels including direct sales, distributors, and online salesand are utilized by varied end users such as hospitals, cardiac centers, ambulatory surgical centers, and other healthcare facilities.

What Is The Atrial Fibrillation Devices Market Growth Forecast?

The atrial fibrillation devices market size is expected to see rapid growth in the next few years. It will grow to $14.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to advancements in ablation technologies, increasing use of remote patient monitoring, rising awareness of stroke prevention, expansion of ambulatory surgical centers, technological innovation in mapping and navigation systems. Major trends in the forecast period include rising adoption of catheter ablation procedures, growing use of wearable and remote ecg monitoring devices, increasing demand for minimally invasive afib treatments, expansion of left atrial appendage closure device usage, improved focus on early detection and long-term rhythm monitoring.

Global Atrial Fibrillation Devices Market Segmentation

1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices 2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products 3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies 4) By Distribution Channel: Direct Sales, Distributors, Online Sales 5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors 2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors 3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

What Is The Driver Of The Atrial Fibrillation Devices Market?

The growing burden of cardiovascular diseases is expected to propel the growth of the atrial fibrillation device market going forward. Cardiovascular diseases refer to disorders affecting the heart and blood vessels, including heart attacks, strokes, and hypertension. The prevalence of cardiovascular diseases is increasing due to the global rise in obesity and diabetes, coupled with the widespread adoption of sedentary lifestyles and poor dietary habits. Atrial fibrillation (AFib) devices play a vital role in managing cardiovascular diseases by detecting, monitoring, and treating irregular heart rhythms, which are often associated with or caused by underlying heart conditions. For instance, in June 2024, according to data published by the American Heart Association, a US-based public health organization, as high blood pressure is expected to increase from 51.2% to 61.0%, the number of people diagnosed with cardiovascular diseases is projected to rise from 128 million in 2020 to over 184 million by 2050. Therefore, the increase in cardiovascular diseases is driving the growth of the atrial fibrillation device industry.

Key Players In The Global Atrial Fibrillation Devices Market

Major companies operating in the atrial fibrillation devices market are Johnson And Johnson Services Inc, Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips NV, Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology, Medtronic Cardiac Rhythm And Heart Failure, Boston Scientific Electrophysiology

Global Atrial Fibrillation Devices Market Trends and Insights

Major companies operating in the atrial fibrillation devices market are focusing on advancements in technologies, such as patient-centric clinical decision support tools, to enhance diagnostic accuracy, personalize treatment plans, and improve overall patient outcomes. Patient-centric clinical decision support tools are digital solutions that help healthcare professionals tailor treatment decisions by analyzing individual patient data. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched CardioVisio for Atrial Fibrillation, a digital clinical decision support tool designed to streamline clinician workflows and support precision care for patients with atrial fibrillation. It allows healthcare providers to visualize the progression of AFib, including previous diagnoses, treatments, medications, and associated conditions. The platform offers guideline-based therapy recommendations, helping to reduce diagnostic errors and streamline clinical decision-making. CardioVisio organizes fragmented patient information into an accessible format, easing the burden on medical staff and enabling more timely, personalized, and effective management of atrial fibrillation.

What Are Latest Mergers And Acquisitions In The Atrial Fibrillation Devices Market?

In November 2023, Johnson & Johnson MedTech, a US-based medical technology company, acquired Laminar Inc. for an undisclosed amount. Through this acquisition, Johnson & Johnson MedTech aims to strengthen its position in the atrial fibrillation device market and expand its portfolio with advanced solutions for stroke prevention and cardiac care. Laminar Inc. is a US-based company developing innovative left atrial appendage elimination devices for stroke prevention in patients with atrial fibrillation.

Regional Outlook

North America was the largest region in the atrial fibrillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Atrial Fibrillation Devices Market?

The atrial fibrillation devices market consists of revenues earned by entities providing services such as diagnostic services, therapeutic services, and patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial fibrillation devices market also includes sales of cryoablation catheters, laser ablation systems, and hybrid ablation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.